In the Spotlight

XXIst European Days of the French Society of Cardiology
The “XXIst European Days of the French Society of Cardiology” is attended by more than 9000 experts each year. From January 12th to 15th, all the most recent discoveries in the field of cardiac arrhythmias will be presented to a community of ...+
Sorin Group Announces Publication of Full CLEAR Study Results in Peer Reviewed Cardiology Journal
Results published in EUROPACE show significant improvement in heart failure patients’ response to cardiac resynchronization therapy with Sorin’s innovative SonR®[1] automatic CRT optimization system Boston, US, May 9th, 2012 –Sorin Group, ...+
Sorin Group Announces FDA Approval and Commercial Launch of Complete Portefolio of Implantable Heart Device Leads
New pacing, defibrillation and left ventricular leads, combined with Sorin Group’s innovative implantable devices enable effective management of arrhythmias and heart failure. Boston, US, May 10th, 2012 –Sorin Group, (Reuters Code: SORN.MI), a global medical device ...+
SORIN welcomes you to HRS 2012 !
SORIN Exhibit Booth & Innovation Lab • Booth #1333 At SORIN GROUP, we are relentlessly committed to better patient outcomes. We encourage imagination and translate our engineering excellence into clinically meaningful technologies. Across the globe, we strive to offer ...+
1 of 1

News

All news

Events

2012

No events

All events
Up